HTGM

HTG Molecular Diagnostics, Inc. Common Stock
HTGM

Overview Fund Activity
Delisted

HTGM was delisted on the 14th of June, 2023.

Back to rankings

23 hedge funds and large institutions have $7.34M invested in HTG Molecular Diagnostics, Inc. Common Stock in 2020 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 5 increasing their positions, 8 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
23
Holders Change
-5
Holders Change %
-17.86%
% of All Funds
0.41%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
5
Reduced
8
Closed
12
Calls
–
Puts
$18K
Net Calls
-$18K
Net Calls Change
-$22K

Top Buyers

1
CPA
1
Cowen Prime Advisors
New York
$2.12M
2
Squarepoint
2
Squarepoint
New York
$123K
3
NCM
3
Nantahala Capital Management
Connecticut
$1.74M
4
TRCT
4
Tower Research Capital (TRC)
New York
$51K
5
Geode Capital Management
5
Geode Capital Management
Massachusetts
$167K

Top Sellers

1
PCM
1
Perkins Capital Management
Minnesota
$0
2
GCP
2
GSA Capital Partners
United Kingdom
$217K
3
Bank Julius Baer & Co
3
Bank Julius Baer & Co
Switzerland
$0
4
Qube Research & Technologies (QRT)
4
Qube Research & Technologies (QRT)
United Kingdom
$58K
5
WG
5
Winton Group
United Kingdom
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
State Street
26
State Street
Massachusetts
– -$8K -126 Closed
Charles Schwab
27
Charles Schwab
California
– -$7K -104 Closed
VF
28
Virtu Financial
New York
– -$4K -67 Closed
CFGS
29
Concourse Financial Group Securities
Alabama
– -$2K -28 Closed
1
2